NPN

NPN April 2011

National Petroleum News (NPN) has been the independent voice of the petroleum industry since 1909 as the opposition to Rockefeller’s Standard Oil. So, motor fuels marketing and retail is not just a sideline for us, it’s our core competency.

Issue link: http://read.dmtmag.com/i/29053

Contents of this Issue

Navigation

Page 10 of 23

NATONEWS Menthol Recommendations and the Industry Response The TPSAC final report O Thomas Briant is execu- tive director of the National Association of Tobacco Outlets. NATO’s toll-free number is (866) 869-8888 and the association’s Web site address is www.natocentral.org. N MARCH 18TH, THE FDA’S TOBACCO Product Scientific Advisory Committee (TPSAC) issued its final report and set of recommendations on the impact of the use of men- thol in cigarettes on the public health. Under the Family Smoking Prevention and Tobacco Control Act enacted into law, which authorized the Food and Drug Administration to regulate cigarettes, RYO tobacco and smokeless tobacco, the TPSAC was required to address the risks and benefits of menthol cigarettes to smokers and non-smokers, the increased or decreased likelihood that existing users of tobacco products will stop using men- thol cigarettes, and the increased or decreased likelihood that those who do not use tobacco products will start using such products. TPSAC FINDINGS The TPSAC final report and set of recommenda- tions enumerated a number of findings and con- clusions including the following: 1. The evidence does not indicate increased dis- ease risks in smokers of menthol cigarettes compared to non-menthol cigarettes. 2. The availability of menthol cigarettes has led to an increase in the number of smokers and that this increase does have an adverse public health impact in the United States. 3. The removal of menthol cigarettes from the marketplace would benefit the public health in the United States. 4. A potential exists for contraband menthol ciga- rettes if the FDA chooses to implement a ban or restrict the availability of menthol cigarettes. Dr. Lawrence Deyton, the director of the FDA’s Center for Tobacco Products, issued a statement indicating that the TPSAC report will undergo a thorough review by experts within the FDA’s Center for Tobacco Products. INDUSTRY RESPONSE Tobacco industry manufacturers and the three www.npnweb.com  NPN Magazine non-voting industry members of the FDA’s Tobacco Product Scientific Advisory Committee have compiled an industry viewpoint report in response to the TPSAC’s findings and recommen- dations on menthol cigarettes. The industry’s report was prepared by scientists with many decades of knowledge and experience in research involving tobacco, cigarettes and menthol. The key highlights of the industry’s report includes the following conclusions: 1. The evidence is suggestive of no causal relation- ship between menthol cigarettes and any dis- proportionate impact on the public health as a whole or for any demographic group when compared to non-menthol cigarettes. 2. The scientific data demonstrates that there is no difference in disease, initiation, cessation or dependence between menthol and non-men- thol cigarettes. 3. There is no scientific basis to support the regu- lation of menthol cigarettes any differently than non-menthol cigarettes. 4. The available scientific studies clearly demon- strate that smokers of menthol cigarettes are at no greater risk of developing chronic smoking- related diseases than are non-menthol smokers. 5. The vast majority of studies of exposure to cig- arette smoke constituents and of potential harm have found no meaningful differences between menthol and non-menthol smokers. 6. The evidence is inadequate to conclude that menthol cigarettes influence higher or earlier smoking initiation by the general population or subgroups of the population. 7. The most relevant studies do not indicate that smokers of menthol cigarettes are less likely to quit than smokers of non-menthol cigarettes. 8. Menthol cigarette smokers are not any more dependent on tobacco nicotine than non-men- thol smokers. 9. A ban on menthol cigarettes would result in a dramatically larger illegal cigarette market than currently exists which would lead to severe neg- ative impacts on public health. There is no timetable or requirement that the FDA take any regulatory action on menthol in cig- arettes. The FDA will issue its first progress report on reviewing the TPSAC recommendations and the industry response by June 23, 2011. APRIL 2011 11

Articles in this issue

Links on this page

Archives of this issue

view archives of NPN - NPN April 2011